Study of prediabetes with abnormal sugars and medicines
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 65 and you have prediabetes test results (fasting and/or 2-hour sugar).
- Your BMI is between 24 and 40, and your weight has stayed fairly steady in the last 3 months.
- You have no known major health problems based on history, physical exam, and blood/urine tests.
- If you can get pregnant, you must use reliable birth control and have a negative pregnancy test before and during the study.
- You must be able and willing to attend scheduled visits, take tests, and follow study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a food supplement that could help people with higher than normal blood sugar, but not yet diabetes. The goal is to see if it can improve blood sugar levels and insulin resistance.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial tests how two diabetes medications, SGLT2i and pioglitazone, affect ketone production in people with type 1 diabetes. It aims to find new ways to improve blood sugar control.
This study tests how a type of diabetes medicine called SGLT2 inhibitors affects how the liver makes sugar. It may help researchers better understand how to manage blood sugar in people with type 2 diabetes.
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
This trial tests if a drug called dapagliflozin (an SGLT2 inhibitor) can help prevent complications in people with prediabetes when added to lifestyle changes. It aims to see if this approach works better than lifestyle changes alone.
Hear when a new Impaired Fasting Glucose (IFG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.